Antibiotic Adjuvant Therapy for Multi-Drug Resistant Carbapenemases Producing Klebsiella pneumoniae Associated Sepsis: A Case Study
Published: April 1, 2016 | DOI: https://doi.org/10.7860/JCDR/2016/.7697
Robin Gupta
1. Medical Practitioner, Government Medical College and Hospital, Chandigarh, India.
Correspondence
Dr. Robin Gupta,
Government Medical College and Hospital, Chandigarh-160030, India.
E-mail: guptarobin@hotmail.com
Rising resistance and spread of K. pneumoniae strains, create great concerns in treating sepsis patients due to high incidence of mortality and morbidity. The current study is a case of a 20-year-old male with sepsis and bilateral lung lesions infected with Multi-Drug Resistant (MDR) carbapenemase producing K. pneumoniae (KPC) showing resistance to carbapenem and polymyxin. Based on sensitivity report, patient was put on antibiotic adjuvant: Elores (ceftriaxone, sulbactam, disodium edetate) along with fluconazole for 10 days. Elores was instituted with remarkable recovery and patient was discharged.
[
FULL TEXT ] | [ PDF]